Recruiting studies: Neuroprotective Drugs

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke
Phase 3 · 6 location(s) · Tatchempharmpreparaty, JSC · NCT07167550 NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy
Phase 2 · 9 location(s) · NoNO Inc. · NCT06403267 Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest
Phase 2 · 2 location(s) · Christian Hassager · NCT06744361 Neuroprotective Effect of Butylphthalide for Cardiac Arrest Patients
Phase 4 · 1 location(s) · Tang Ziren · NCT06572085 Neuroprotective Effect of (Nano PSO), in Patients Who Used to Consume Psychoactive Substances
NA · 1 location(s) · Distribuidora Biolife SA de CV · NCT06550167 Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular T
Phase 2 · 14 location(s) · Shanghai QuietD Biotechnology Co., Ltd. · NCT07581210 Butylphthalide's Safety and Efficacy for Improving Neurological Function Prognosis in Patients With Cardiac Arrest (BNCA
Phase 4 · 1 location(s) · Tang Ziren · NCT06353334

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.